Myriad----++++In transgenic mouse studies, Flurizan has demonstrated the ability to reduce brain amyloid levels and prevent memory loss.
How or are they measuring amyloid levels in the Phase II study? AXYX is conducting a Phase II study specifically testing the amyloid levels in cerebropsinal fluid to 'prove' Phenserine is responsible for reduction--if any.